Watson Pharmaceutical announced that the company recently received the “Chemical Ingredient Re-Registration Approval Notice” for the chemical ingredient aluminum and magnesium carbonate and the “Drug Re-Registration Approval Notice” for the drug troxerutin injection approved and issued by the Chongqing Drug Administration. Aluminum magnesium carbonate tablets are first-line medicines for the digestive system. They are suitable for treating various gastric diseases, and can be widely used in gastroenterology, emergency departments, otolaryngology, etc. Troxerutin injections are used for ischemic cerebrovascular disease, etc.

Watson Pharmaceutical announced that the company recently received the “Chemical Ingredient Re-Registration Approval Notice” for the chemical ingredient aluminum and magnesium carbonate and the “Drug Re-Registration Approval Notice” for the drug troxerutin injection approved and issued by the Chongqing Drug Administration. Aluminum magnesium carbonate tablets are first-line medicines for the digestive system. They are suitable for treating various gastric diseases, and can be widely used in gastroenterology, emergency departments, otolaryngology, etc. Troxerutin injections are used for ischemic cerebrovascular disease, etc.